.png)
Do your mental health programs have any impact?
BENCHMARK YOUR BENEFITS
Investing in mental health benefits is a great first step to increasing access to care for your employees.
Now it’s time to make sure the benefits you’ve selected are making their desired impact.
This Mental Health Benefits Impact Interactive Tool will guide you through simple questions that can help measure the effectiveness of your current program.
Key actionable takeaways:
- Are your benefits reaching everyone equally?
- Do your benefits provide sufficient and appropriate access to gold-standard care?
- How does your program stack up compared to industry benchmarks?
Measure the impact of your mental health benefits
Cultivating mental health equity in the workplace can feel like an insurmountable challenge. But most big transformations come from the hundreds of small steps we take along the way. Mental health equity is no different. Answer the questions below to take the first step:
Mental health care for all, no prescription necessary
Sleepio®, for poor sleep and insomnia, addresses unique needs with a personalized program, featuring sessions with step-by-step guidance through evidence-based techniques, available night or day. In a UK clinical trial, 76% of patients experienced improvement in their sleep2.
Start Sleepio today:
Mental health care for all, no prescription necessary
Sleepio®, for poor sleep and insomnia, addresses unique needs with a personalized program, featuring sessions with step-by-step guidance through evidence-based techniques, available night or day. In a UK clinical trial, 76% of patients experienced improvement in their sleep2.
Start Sleepio today:
Sleepio and Daylight are available as an adjunct to usual medical care for insomnia disorder or generalized anxiety disorder, respectively, for adults ages 18 and older, without FDA review under their COVID-19 policy. Users are directed to not make any changes to their prescribed medication or other type of medical treatment without seeking professional medical advice.
1. Claims data provided from 25 self-insured employers consisting of pharmacy and medical claims associated with insomnia and anxiety.
2. ‘Improvement in sleep’ defined as 80% or more of total time in bed being spent asleep at the end of the clinical trial. Espie, C. A., Kyle, S. D., Williams, C., Ong, J. C., Douglas, N. J., Hames, P., & Brown, J. S. (2012). A randomized, placebo-controlled trial of online cognitive behavioral therapy for chronic insomnia disorder delivered via an automated media-rich web application. Sleep, 35(6), 769-781.
3. Probable clinical diagnosis of anxiety defined as reporting levels of anxiety below the threshold for a clinical diagnosis of anxiety at a follow-up point 10 weeks after the start of treatment. Carl, J. R., Miller, C. B., Henry, A. L., Davis, M. L., Stott, R., Smits, J. A., … & Espie, C. A. (2020). Efficacy of digital cognitive behavioral therapy for moderate-to-severe symptoms of generalized anxiety disorder: A randomized controlled trial. Depression and Anxiety, 37(12), 1168-1178